eFFECTOR Therapeutics CEO Stephen Worland's 2021 pay jumps 428% to $3.4M
eFFECTOR Therapeutics reports 2021 executive compensation
By ExecPay News
Published: April 20, 2022
eFFECTOR Therapeutics reported fiscal year 2021 executive compensation information on April 20, 2022.
In 2021, four executives at eFFECTOR Therapeutics received on average a compensation package of $2M, a 182% increase compared to previous year.
Average pay of disclosed executives at eFFECTOR Therapeutics
Stephen T. Worland, Chief Executive Officer, received $3.4M in total, which increased by 428% compared to 2020. 78% of Worland's compensation, or $2.7M, was in stock awards. Worland also received $220K in non-equity incentive plan, $501K in salary, as well as $32K in other compensation.
Alana McNulty, Chief Business Officer, received a compensation package of $1.7M, which increased by 198% compared to previous year. 68% of the compensation package, or $1.2M, was in stock awards.
Premal Patel, Chief Medical Officer, earned $1.5M in 2021, a 60% increase compared to previous year.
Michael Byrnes, Chief Financial Officer, received $1.2M in 2021, which increases by 100% compared to 2020.
Related executives
You may also like
Source: SEC filing on April 20, 2022.